Heartland Advisors’s AbbVie ABBV Stock Holding History

Heartland Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-30,861	Closed	-$2.02M	–	244
2014 Q4	$2.02M	Sell	30,861 -1,781	-5%	-$112K	0.04%	229
2014 Q3	$1.89M	Sell	32,642 -5,770	-15%	-$320K	0.04%	229
2014 Q2	$2.17M	Buy	38,412 +1,831	+5%	+$96.1K	0.04%	229
2014 Q1	$1.88M	Sell	36,581 -6,429	-15%	-$325K	0.03%	230
2013 Q4	$2.27M	Sell	43,010 -3,464	-7%	-$170K	0.04%	223
2013 Q3	$2.08M	Sell	46,474 -345	-0.7%	-$15.3K	0.04%	227
2013 Q2	$1.94M	Buy	+46,819	New	+$2.05M	0.04%	237

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Heartland Advisors's ABBV Position: Q1 2015 in Review

Heartland Advisors sold out of AbbVie (ABBV) in Q1 2015, closing a stake of 30,861 shares — an estimated $2.02M sold.

Heartland Advisors first reported a position in ABBV in Q2 2013 and held it in 7 quarters. The position peaked at $2.27M in Q4 2013. 1,601 funds tracked by Wall St. Rank hold ABBV as of Q1 2015.

Heartland Advisors reported no remaining AbbVie position as of Q1 2015 after selling out during the quarter.
Heartland Advisors sold 30,861 AbbVie shares in Q1 2015, an estimated $2.02M.
Heartland Advisors first reported a position in AbbVie in Q2 2013 and held it in 7 quarters.
Heartland Advisors's AbbVie position peaked at $2.27M in Q4 2013.
1,601 funds tracked by Wall St. Rank held AbbVie as of Q1 2015.

Based on Heartland Advisors's 13F filing for Q1 2015, filed 12 May 2015.